Sunday, August 2, 2015

AmerisourceBergen CFO departs immediately

Valley Forge-based AmerisourceBergen, one of the nation's biggest pharmaceutical wholesalers, said that chief financial officer Michael D. DiCandilo has left the company to "pursue other interests," effective immediately.

AmerisourceBergen CFO departs immediately

0 comments

Valley Forge-based AmerisourceBergen, one of the nation's biggest pharmaceutical wholesalers, said that chief financial officer Michael D. DiCandilo has left the company to "pursue other interests," effective immediately.

Tim G. Guttman, the company's vice president and corporate controller since 2002, will serve as acting CFO, the company said.

"Mike departs the company with an impeccable record of service over his 21 years, including the past ten as our chief financial officer," Steven H. Collis, president and chief executive officer of AmerisourceBergen said in a statement. "His tremendous contributions to the success of AmerisourceBergen through his fiscal leadership and business stewardship are greatly appreciated, and we wish him all the best in his future endeavors."

Guttman was previously Vice President, Finance of Syncor International, and held financial planning and financial services managerial positions at Disney Consumer Products, Pizza Hut, Inc. and PepsiCo, Inc.. Guttman started his career as a certified public accountant with accounting firm Deloitte & Touche.

DiCandilo could not be reached for comment.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter